As far as I can tell, nobody asked the authors to provide a reference or link to the past NIAID Strategic Plans that they mischaracterize in the piece.
Within four months of publication, Taubenberger was gone.
Within four months of publication, Taubenberger was gone.
In January, NIH's Jay Bhattacharya and Jeff Tautenberger ran an op-ed on NIAID's "new vision" in Nature Medicine. www.nature.com/articles/s41...
For the historical record, here are the edits on the op-ed, acquired by #FOIA: www.documentcloud.org/documents/28...
For the historical record, here are the edits on the op-ed, acquired by #FOIA: www.documentcloud.org/documents/28...
Jay Bhattacharya & Jeff Tautenberger op-ed edits on NIAID's 2026 "new vision" in Nature Medicine.
www.documentcloud.org
November 3, 2026 at 4:01 PM
As far as I can tell, nobody asked the authors to provide a reference or link to the past NIAID Strategic Plans that they mischaracterize in the piece.
Within four months of publication, Taubenberger was gone.
Within four months of publication, Taubenberger was gone.
#NIHFunding to establish Translational Centers using human cell-based MPS to study infectious diseases & advance medical interventions.
From NIAID, OAR, & ORIVA
files.simpler.grants.gov/opportunitie...
#funding #NIH #IDsky #HIVsky #virology #virosky #microsky #infectiousdisease
From NIAID, OAR, & ORIVA
files.simpler.grants.gov/opportunitie...
#funding #NIH #IDsky #HIVsky #virology #virosky #microsky #infectiousdisease
October 31, 2026 at 5:10 PM
#NIHFunding to establish Translational Centers using human cell-based MPS to study infectious diseases & advance medical interventions.
From NIAID, OAR, & ORIVA
files.simpler.grants.gov/opportunitie...
#funding #NIH #IDsky #HIVsky #virology #virosky #microsky #infectiousdisease
From NIAID, OAR, & ORIVA
files.simpler.grants.gov/opportunitie...
#funding #NIH #IDsky #HIVsky #virology #virosky #microsky #infectiousdisease
![From:
Sent:
To:
Powers, John (NIH/NIAID) [C]
Subject:
Williams, Laci (NIH/OD) [E] Mon, 12 Jan 2026 14:10:41 + Taubenberger, Jeffery (NIH/T
Re: [EXTERNAL] Your Nature
Thanks Jeff. We have the roll-out plan ready
In freedom,
Laci Williams
National Institutes of Health
Office of the Director
Director of Strategic Communications
Laci.williams@nih.gov](https://cdn.bsky.app/img/feed_thumbnail/plain/did:plc:p66b7zkep57fp4rhrtktsdni/bafkreibadldoalms32ag7ab2qz5ahywz5bsimh3yvoopzzxdje2jzrv2ni)
A unique human challenge study illuminates how dengue immunity shapes the nature of repeated infections, researchers identify a targetable molecular driver of skin inflammation in psoriasis, and more this week in #ScienceTranslationalMedicine. https://scim.ag/3W8yhmA
October 28, 2026 at 9:00 PM
A unique human challenge study illuminates how dengue immunity shapes the nature of repeated infections, researchers identify a targetable molecular driver of skin inflammation in psoriasis, and more this week in #ScienceTranslationalMedicine. https://scim.ag/3W8yhmA
On this day in COVID history, November 1, 2020:
Dr Anthony Fauci is the only figure to find his approval rating rise after be...
Source: The Independent
https://www.independent.co.uk/news/world/americas/us-election-2020/anthony-fauci-donald-trump-approval-rating-niaid-covid-b1486421.html
Dr Anthony Fauci is the only figure to find his approval rating rise after be...
Source: The Independent
https://www.independent.co.uk/news/world/americas/us-election-2020/anthony-fauci-donald-trump-approval-rating-niaid-covid-b1486421.html
November 1, 2026 at 1:40 PM
On this day in COVID history, November 1, 2020:
Dr Anthony Fauci is the only figure to find his approval rating rise after be...
Source: The Independent
https://www.independent.co.uk/news/world/americas/us-election-2020/anthony-fauci-donald-trump-approval-rating-niaid-covid-b1486421.html
Dr Anthony Fauci is the only figure to find his approval rating rise after be...
Source: The Independent
https://www.independent.co.uk/news/world/americas/us-election-2020/anthony-fauci-donald-trump-approval-rating-niaid-covid-b1486421.html
OT Amy Mooney explores how the change in seasons may bring changes in symptoms for people with ME/CFS and LC. It can be an additional stressor affecting PEM. Learn to recognize how it affects you and how to adapt to what your body is being asked to manage.
tinyurl.com/36kk28au
tinyurl.com/36kk28au
When the Seasons Change: Seasonal Transition as an Exertional Stressor
A new NIH/NIAID strategic vision signals increased attention to post-infectious conditions like ME/CFS and Long COVID.
tinyurl.com
November 3, 2026 at 12:56 PM
OT Amy Mooney explores how the change in seasons may bring changes in symptoms for people with ME/CFS and LC. It can be an additional stressor affecting PEM. Learn to recognize how it affects you and how to adapt to what your body is being asked to manage.
tinyurl.com/36kk28au
tinyurl.com/36kk28au
Seasonal Changes & Pacing for PEM: Temperature, daylight & changing routines can add to cumulative exertion. @batemanhornecenter.bsky.social OT Amy Mooney shares strategies for tracking capacity, adapting activities & planning rest. batemanhornecenter.org/when-the-sea...
When the Seasons Change: Seasonal Transition as an Exertional Stressor
A new NIH/NIAID strategic vision signals increased attention to post-infectious conditions like ME/CFS and Long COVID.
batemanhornecenter.org
October 28, 2026 at 2:38 AM
Seasonal Changes & Pacing for PEM: Temperature, daylight & changing routines can add to cumulative exertion. @batemanhornecenter.bsky.social OT Amy Mooney shares strategies for tracking capacity, adapting activities & planning rest. batemanhornecenter.org/when-the-sea...
Advance scientific discoveries with 230K+ NIAID-funded influenza samples from completed clinical studies in the Flu Hub Clinical Biospecimen Repository with the help of HANA AI. Learn more: https://ow.ly/FoLM5101OiC
October 28, 2026 at 6:01 PM
Advance scientific discoveries with 230K+ NIAID-funded influenza samples from completed clinical studies in the Flu Hub Clinical Biospecimen Repository with the help of HANA AI. Learn more: https://ow.ly/FoLM5101OiC
התסמינים מופיעים לרוב 4–10 ימים לאחר העקיצה, ונמשכים בין יומיים לשבעה ימים.
בכחמישה אחוזים מהחולים, המחלה מסתבכת לקדחת דנגי חמורה עם דימומים פנימיים וחיצוניים (מהאף, מהחניכיים ומערכת העיכול), כאבי בטן עזים, כשל מערכתי והלם שעלול להוביל למוות בהיעדר טיפול תומך מיידי באשפוז.
בכחמישה אחוזים מהחולים, המחלה מסתבכת לקדחת דנגי חמורה עם דימומים פנימיים וחיצוניים (מהאף, מהחניכיים ומערכת העיכול), כאבי בטן עזים, כשל מערכתי והלם שעלול להוביל למוות בהיעדר טיפול תומך מיידי באשפוז.
October 29, 2026 at 10:04 AM
התסמינים מופיעים לרוב 4–10 ימים לאחר העקיצה, ונמשכים בין יומיים לשבעה ימים.
בכחמישה אחוזים מהחולים, המחלה מסתבכת לקדחת דנגי חמורה עם דימומים פנימיים וחיצוניים (מהאף, מהחניכיים ומערכת העיכול), כאבי בטן עזים, כשל מערכתי והלם שעלול להוביל למוות בהיעדר טיפול תומך מיידי באשפוז.
בכחמישה אחוזים מהחולים, המחלה מסתבכת לקדחת דנגי חמורה עם דימומים פנימיים וחיצוניים (מהאף, מהחניכיים ומערכת העיכול), כאבי בטן עזים, כשל מערכתי והלם שעלול להוביל למוות בהיעדר טיפול תומך מיידי באשפוז.
🚨 New preprint from our lab at NIAID! We discovered hundreds of sRNAs and mapped RNA–RNA interactions in the Lyme disease pathogen, revealing a dynamic regulatory network and OspR, an sRNA that directly binds and downregulates the mRNA encoding OspA, the antigen used in Lyme disease vaccines! 🧬
Global RNA-RNA interactome mapping in B. burgdorferi reveals base-pairing sRNAs that rewire gene expression across growth
Small RNAs (sRNAs) are prevalent across the bacterial kingdom and produce diverse regulatory effects when base pairing with target RNAs. To better identify sRNAs, we designed an experimental and compu...
www.biorxiv.org
October 28, 2026 at 10:56 AM
🚨 New preprint from our lab at NIAID! We discovered hundreds of sRNAs and mapped RNA–RNA interactions in the Lyme disease pathogen, revealing a dynamic regulatory network and OspR, an sRNA that directly binds and downregulates the mRNA encoding OspA, the antigen used in Lyme disease vaccines! 🧬
Somebody explain to me why an NIH study would be called an NIH Center, especially if there is no clinical element taking place at NIH.
(So it's a data-based observational study?)
Is this standard nomenclature (as in a multi-site study is called a Center) or not?
www.statnews.com/2026/10/26/n...
(So it's a data-based observational study?)
Is this standard nomenclature (as in a multi-site study is called a Center) or not?
www.statnews.com/2026/10/26/n...
October 31, 2026 at 3:43 PM
Somebody explain to me why an NIH study would be called an NIH Center, especially if there is no clinical element taking place at NIH.
(So it's a data-based observational study?)
Is this standard nomenclature (as in a multi-site study is called a Center) or not?
www.statnews.com/2026/10/26/n...
(So it's a data-based observational study?)
Is this standard nomenclature (as in a multi-site study is called a Center) or not?
www.statnews.com/2026/10/26/n...
Trials We Love!
What’s happening?
NIH’s NIAID is recruiting healthy adults ages 18–50 for a dengue human challenge study, in which volunteers receive a weakened dengue virus so researchers can see how the body responds.
What’s happening?
NIH’s NIAID is recruiting healthy adults ages 18–50 for a dengue human challenge study, in which volunteers receive a weakened dengue virus so researchers can see how the body responds.
October 28, 2026 at 12:30 AM
Trials We Love!
What’s happening?
NIH’s NIAID is recruiting healthy adults ages 18–50 for a dengue human challenge study, in which volunteers receive a weakened dengue virus so researchers can see how the body responds.
What’s happening?
NIH’s NIAID is recruiting healthy adults ages 18–50 for a dengue human challenge study, in which volunteers receive a weakened dengue virus so researchers can see how the body responds.
Dr. Penelope Markham, SVP & Program Lead for Long COVID, will share results from our P2 ADDRESS-LC trial of bezisterim for the treatment of neurological symptoms of #LongCOVID on Thurs, November 5, at the 2026 RECOVER-TLC Workshop, hosted by NIAID & FNIH.
investors.bioviepharma.com/news/news-de...
investors.bioviepharma.com/news/news-de...
October 26, 2026 at 7:23 PM
Dr. Penelope Markham, SVP & Program Lead for Long COVID, will share results from our P2 ADDRESS-LC trial of bezisterim for the treatment of neurological symptoms of #LongCOVID on Thurs, November 5, at the 2026 RECOVER-TLC Workshop, hosted by NIAID & FNIH.
investors.bioviepharma.com/news/news-de...
investors.bioviepharma.com/news/news-de...
Dr @celinegounder.com opening her talk at #IDweek with the fact that the current IDSA president was fired by the HHS secretary as head of NIAID. Really laying out the assault on science that this administration is undertaking 🔥🔥💪🏼
October 22, 2026 at 9:02 PM
Dr @celinegounder.com opening her talk at #IDweek with the fact that the current IDSA president was fired by the HHS secretary as head of NIAID. Really laying out the assault on science that this administration is undertaking 🔥🔥💪🏼
Wasn't this one of the stars in The Matrix?
www.independent.co.uk/news/science...
www.independent.co.uk/news/science...
October 23, 2026 at 9:51 PM
Wasn't this one of the stars in The Matrix?
www.independent.co.uk/news/science...
www.independent.co.uk/news/science...
NIH Vaccinology & Immunology Center Update: Research to investigate serious post-vaccination health problems & persistent symptoms after infections, incl. LC but ME/CFS eligibility not clear. www.nih.gov/about-nih/ni...
Statement from NIH Director Jay Bhattacharya and NIAID Acting Director John H. Powers III on the New NIH Vaccinology and Immunology Center
The center will bring together patients, physician-scientists, and laboratory researchers to investigate health problems following vaccination and infections, and turn discoveries into better care and...
www.nih.gov
October 26, 2026 at 2:09 AM
NIH Vaccinology & Immunology Center Update: Research to investigate serious post-vaccination health problems & persistent symptoms after infections, incl. LC but ME/CFS eligibility not clear. www.nih.gov/about-nih/ni...
October 22, 2026 at 6:35 PM
2010 #BeckmanScholar Nicholas Jarjour, PhD receives NIAID DP2 New Innovators Award
October 22, 2026 at 10:46 PM
2010 #BeckmanScholar Nicholas Jarjour, PhD receives NIAID DP2 New Innovators Award
NIAID NOFO: Immune Tolerance Network (UM1 Clinical Trial Required)
Program Funding: $21,986,000
1 Expected award
bit.ly/4eakguX
Program Funding: $21,986,000
1 Expected award
bit.ly/4eakguX
October 21, 2026 at 6:15 PM
NIAID NOFO: Immune Tolerance Network (UM1 Clinical Trial Required)
Program Funding: $21,986,000
1 Expected award
bit.ly/4eakguX
Program Funding: $21,986,000
1 Expected award
bit.ly/4eakguX
immunologist who served as the director of the National Institute of Allergy and Infectious Diseases (NIAID).
He led federal responses to multiple global health crises, including HIV/AIDS, swine flu, Ebola, and COVID 19.
I am embarrassed for Navarro but not surprised. .
I am grateful for Dr. Fauci.
He led federal responses to multiple global health crises, including HIV/AIDS, swine flu, Ebola, and COVID 19.
I am embarrassed for Navarro but not surprised. .
I am grateful for Dr. Fauci.
October 20, 2026 at 3:53 PM
immunologist who served as the director of the National Institute of Allergy and Infectious Diseases (NIAID).
He led federal responses to multiple global health crises, including HIV/AIDS, swine flu, Ebola, and COVID 19.
I am embarrassed for Navarro but not surprised. .
I am grateful for Dr. Fauci.
He led federal responses to multiple global health crises, including HIV/AIDS, swine flu, Ebola, and COVID 19.
I am embarrassed for Navarro but not surprised. .
I am grateful for Dr. Fauci.
Kenya reports more Ebola cases, all linked to initial patient
Also, new data show that 1 in 4 new patients in North Kivu, DRC, are children.
Read more: https://bit.ly/47pzFnh
📷: NIAID/Flickr cc
Also, new data show that 1 in 4 new patients in North Kivu, DRC, are children.
Read more: https://bit.ly/47pzFnh
📷: NIAID/Flickr cc
October 19, 2026 at 9:27 PM
Kenya reports more Ebola cases, all linked to initial patient
Also, new data show that 1 in 4 new patients in North Kivu, DRC, are children.
Read more: https://bit.ly/47pzFnh
📷: NIAID/Flickr cc
Also, new data show that 1 in 4 new patients in North Kivu, DRC, are children.
Read more: https://bit.ly/47pzFnh
📷: NIAID/Flickr cc
Soundboard Jay is now trying to conflate vaccine injury and Long COVID as indistinguishable: “Americans suffering from Long COVID have highlighted the reality that many infections can cause long-term symptoms often indistinguishable from adverse events after vaccination” www.nih.gov/about-nih/ni...
Statement from NIH Director Jay Bhattacharya and NIAID Acting Director John H. Powers III on the New NIH Vaccinology and Immunology Center
The center will bring together patients, physician-scientists, and laboratory researchers to investigate health problems following vaccination and infections, and turn discoveries into better care and...
www.nih.gov
October 20, 2026 at 11:52 PM
Soundboard Jay is now trying to conflate vaccine injury and Long COVID as indistinguishable: “Americans suffering from Long COVID have highlighted the reality that many infections can cause long-term symptoms often indistinguishable from adverse events after vaccination” www.nih.gov/about-nih/ni...
Dr. Anthony Fauci, American Hero Immunologist director of National Institute of Allergy & Infectious Diseases NIAID 1984 - 2022. During the #COVID19 #Pandemic ☣️, Vaccine 💉mandates & Nonpharmaceutical disease containment measures saved Millions of Lives❗
pmc.ncbi.nlm.nih.gov/articles/PMC...
pmc.ncbi.nlm.nih.gov/articles/PMC...
October 20, 2026 at 12:32 PM
Dr. Anthony Fauci, American Hero Immunologist director of National Institute of Allergy & Infectious Diseases NIAID 1984 - 2022. During the #COVID19 #Pandemic ☣️, Vaccine 💉mandates & Nonpharmaceutical disease containment measures saved Millions of Lives❗
pmc.ncbi.nlm.nih.gov/articles/PMC...
pmc.ncbi.nlm.nih.gov/articles/PMC...